Johnson & Johnson (XSWX:JNJ) Total Tax Payable: CHF856 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:JNJ Johnson & Johnson XSWX:JNJ
76 GF Score
Price CHF204.25
GF Value CHF158.14
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Total Tax Payable?

Johnson & Johnson XSWX:JNJ -0.41% 76 Total Tax Payable is CHF856 Mil as of Mar. 2026. GuruFocus rates XSWX:JNJ with a GF Score™ of 76/100 and a GF Value™ of CHF158.14 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Johnson & Johnson's Total Tax Payable for the quarter that ended in Mar. 2026 was CHF856 Mil.

Johnson & Johnson's quarterly Total Tax Payable declined from Sep. 2025 (CHF1,535 Mil) to Dec. 2025 (CHF1,106 Mil) and declined from Dec. 2025 (CHF1,106 Mil) to Mar. 2026 (CHF856 Mil).

Johnson & Johnson's annual Total Tax Payable increased from Dec. 2023 (CHF2,588 Mil) to Dec. 2024 (CHF3,363 Mil) but then declined from Dec. 2024 (CHF3,363 Mil) to Dec. 2025 (CHF1,106 Mil).

Johnson & Johnson Total Tax Payable Related Terms

Johnson & Johnson Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Total Tax Payable Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,024.15 2,068.15 2,588.35 3,363.12 1,106.10

Johnson & Johnson Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,353.98 1,534.88 1,106.10 855.80 0.00
XSWX:JNJ
76GF Score
Johnson & Johnson XSWX:JNJ
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of CHF856 Mil mean?
Johnson & Johnson (XSWX:JNJ) has a Total Tax Payable of CHF856 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's Total Tax Payable too high?
Johnson & Johnson's current Total Tax Payable is CHF856 Mil. Overall, Johnson & Johnson has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Total Tax Payable compare to ABBV and MRK?
Johnson & Johnson's Total Tax Payable of CHF856 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current Total Tax Payable is CHF856 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (XSWX:JNJ) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF158.14, compared to a current price of CHF204.25 — trading 29.2% above its estimated fair value. The current Total Tax Payable is CHF856 Mil. Johnson & Johnson's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Johnson & Johnson (XSWX:JNJ), the current Total Tax Payable is CHF856 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (XSWX:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of CHF204.25 is trading 29.2% above its estimated GF Value™ of CHF158.14. GuruFocus considers Johnson & Johnson to be Modestly Overvalued.

Key valuation signals for XSWX:JNJ:

  • Total Tax Payable: CHF856 Mil
  • GF Value™: CHF158.14 vs. price of CHF204.25 (29.2% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the XSWX:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
76GF Score

Get the complete analysis for XSWX:JNJ

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF204.25
Price
CHF158.14
GF Value